Peer M. Schatz

Peer Michael Schatz ( born August 3, 1965 in New York City ) is Chairman of the Board of QIAGEN NV

Growing up in the U.S. and Switzerland, studied treasure after graduation (Abitur ) at the Swiss University of St. Gallen Economic and Social Sciences. In 1989 he graduated as lic.oec. from 1990 and acquired in addition to the Master of Business Administration (MBA) from the University of Chicago. His first professional years were marked by different positions in Sandoz and computer country as well as through participation in and co-founding several start-up companies from the IT industry in Switzerland, Germany and the USA.

In 1993 moved to Treasure Qiagen, where he brought Qiagen 1996 the first German company to the NASDAQ and a little later at the Frankfurt Stock Exchange. Treasure turned the company that once marketed a limited product portfolio of university laboratories, in a globally operating technology and market leader in the samples pre- Tung and assay technologies with leading positions for such solutions in the human molecular diagnostics, applied testing (including veterinary diagnostics, forensics ) and in drug development and research. Qiagen 's headcount increased from initially about 50 employees to over 3,700 in 2011.

Treasure to 2011 was a member of the NGO German Corporate Governance Code and the Executive Board in the PMS Asset Management GmbH. He is represented on the boards of American industry organizations AdvaMedDx and ALSSA (Analytical & Life Science Systems Association ). Since June 2008, he is also a member of the Advisory Board of the MBA program Business Integration at the University of Würzburg. From 2002 to 2004 he was a member of the Exchange Council of the Frankfurt Stock Exchange.

Treasure is married to the Swiss Nadine Treasure Grandjean - Perrenoud - Contesse - she is also a graduate of the University of St. Gallen. He is the son of the biochemist and Mitentdeckers of mitochondrial DNA, Gottfried Schatz.

Awards

  • Manager of the Year by the Federal Association of German Management Consultants (BDU ), 2010
  • Best CEO First Place - Institutional Investor All- Europe Executive Team, Biotechnology Industry, Sell Side, 2010
  • Best CEO First Place - Institutional Investor All- Europe Executive Team, Biotechnology Industry, Sell Side, 2011
640262
de